Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

[Dip-slides for culturing urine in general practice].

Thue G, Baerheim A, Bjelkarøy WI, Digranes A.

Tidsskr Nor Laegeforen. 2010 Mar 11;130(5):483-6. doi: 10.4045/tidsskr.09.0658. Review. Norwegian.

2.

Antibiotic susceptibility of blood culture isolates of anaerobic bacteria at a Norwegian university hospital.

Kommedal O, Nystad TW, Bølstad B, Digranes A.

APMIS. 2007 Aug;115(8):956-61.

PMID:
17696952
3.

Candidemia in Norway (1991 to 2003): results from a nationwide study.

Sandven P, Bevanger L, Digranes A, Haukland HH, Mannsåker T, Gaustad P; Norwegian Yeast Study Group.

J Clin Microbiol. 2006 Jun;44(6):1977-81.

4.

[Quality assessment of urine dip-slides in primary care].

Bjelkarøy WI, Sandberg S, Thue G, Digranes A, Høiby EA, Lermark G, Melby KK.

Tidsskr Nor Laegeforen. 2006 Jan 12;126(2):149-52. Norwegian.

5.

A multi-centre prospective study of febrile neutropenia in Norway: microbiological findings and antimicrobial susceptibility.

Sigurdardottir K, Digranes A, Harthug S, Nesthus I, Tangen JM, Dybdahl B, Meyer P, Hopen G, Løkeland T, Grøttum K, Vie W, Langeland N.

Scand J Infect Dis. 2005;37(6-7):455-64.

PMID:
16012006
6.

Surveillance of antimicrobial resistance at a tertiary hospital in Tanzania.

Blomberg B, Mwakagile DS, Urassa WK, Maselle SY, Mashurano M, Digranes A, Harthug S, Langeland N.

BMC Public Health. 2004 Oct 11;4:45.

7.

Susceptibility to quinupristin-dalfopristin and linezolid in 839 clinical isolates of Gram-positive cocci from Norway.

Simonsen GS, Bergh K, Bevanger L, Digranes A, Gaustad P, Melby KK, Høiby EA.

Scand J Infect Dis. 2004;36(4):254-8.

PMID:
15198180
8.

Comparison of PCR detection of mecA with agar dilution and Etest for oxacillin susceptibility testing in clinical isolates of coagulase-negative staphylococci.

Tveten Y, Jenkins A, Digranes A, Melby KK, Allum AG, Kristiansen BE.

Clin Microbiol Infect. 2004 May;10(5):462-5.

9.
10.
11.

[Urinary tract pathogens in uncomplicated lower urinary tract infections in women in Norway].

Jureen R, Digranes A, Baerheim A.

Tidsskr Nor Laegeforen. 2003 Aug 14;123(15):2021-2. Norwegian.

12.

Outbreak of infection with high-level gentamicin-resistant Enterococcus faecalis (HLGRE) in a Norwegian hospital.

Wendelbo Ø, Jureen R, Eide GE, Digranes A, Langeland N, Harthug S.

Clin Microbiol Infect. 2003 Jul;9(7):662-9.

13.

Factors associated with increased and decreased risk of Campylobacter infection: a prospective case-control study in Norway.

Kapperud G, Espeland G, Wahl E, Walde A, Herikstad H, Gustavsen S, Tveit I, Natås O, Bevanger L, Digranes A.

Am J Epidemiol. 2003 Aug 1;158(3):234-42.

PMID:
12882945
14.

Prevalence of resistance to ampicillin, gentamicin and vancomycin in Enterococcus faecalis and Enterococcus faecium isolates from clinical specimens and use of antimicrobials in five Nordic hospitals.

Simonsen GS, Småbrekke L, Monnet DL, Sørensen TL, Møller JK, Kristinsson KG, Lagerqvist-Widh A, Torell E, Digranes A, Harthug S, Sundsfjord A.

J Antimicrob Chemother. 2003 Feb;51(2):323-31.

PMID:
12562698
15.

Acupuncture treatment in the prevention of uncomplicated recurrent lower urinary tract infections in adult women.

Alraek T, Soedal LI, Fagerheim SU, Digranes A, Baerheim A.

Am J Public Health. 2002 Oct;92(10):1609-11. No abstract available.

16.

The relation between sale of antimicrobial drugs and antibiotic resistance in uropathogens in general practice.

Christiaens TC, Digranes A, Baerheim A.

Scand J Prim Health Care. 2002 Mar;20(1):45-9.

PMID:
12086284
17.

Lactobacillus rhamnosus septicaemia in a patient with a graft in the inferior vena cava.

Jureen R, Søndenaa K, Høiby EA, Digranes A.

Scand J Infect Dis. 2002;34(2):135-6.

PMID:
11928847
18.

Comparative evaluation of a commercial test for rapid identification of methicillin-resistant Staphylococcus aureus.

Jureen R, Bottolfsen KL, Grewal H, Digranes A.

APMIS. 2001 Nov;109(11):787-90.

PMID:
11900059
19.

Antibiotic susceptibility of blood culture isolates of Enterobacteriaceae. A Norwegian multicenter study.

Digranes A, Sjursen H, Melby KK, Solberg CO.

APMIS. 2001 Oct;109(10):641-6.

PMID:
11890566
20.

Molecular epidemiological study of Salmonella enterica serovar paratyphi B infections imported from Turkey to Western Norway.

Grewal HM, Jureen R, Steinsland H, Digranes A.

Scand J Infect Dis. 2002;34(1):5-10.

PMID:
11878291
21.

The prevalence of faecal carriage of ampicillin-resistant and high-level gentamicin-resistant enterococci among inpatients at 10 major Norwegian hospitals.

Harthug S, Jureen R, Mohn SC, Digranes A, Simonsen GS, Sundsfjord A, Langeland N; Norwegian Enterococcal Study Group.

J Hosp Infect. 2002 Feb;50(2):145-54.

PMID:
11846543
22.

Typing of Pseudomonas aeruginosa strains in Norwegian cystic fibrosis patients.

Fluge G, Ojeniyi B, Høiby N, Digranes A, Ciofu O, Hunstad E, Haanaes OC, Storrøsten OT.

Clin Microbiol Infect. 2001 May;7(5):238-43.

23.

Vancomycin resistance emerging in a clonal outbreak caused by ampicillin-resistant Enterococcus faecium.

Harthug S, Digranes A, Hope O, Kristiansen BE, Allum AG, Langeland N.

Clin Microbiol Infect. 2000 Jan;6(1):19-28.

24.

Eradication of non-typhoid salmonellae in acute enteritis after therapy with ofloxacin for 5 or 10 days.

Voltersvik P, Halstensen A, Langeland N, Digranes A, Peterson LE, Rolstad T, Solberg CO.

J Antimicrob Chemother. 2000 Sep;46(3):457-9.

PMID:
10980174
25.

[Outbreak of multiresistant Acinetobacter baumannii infection].

Onarheim H, Høivik T, Harthug S, Digranes A, Mylvaganam H, Vindenes HA.

Tidsskr Nor Laegeforen. 2000 Mar 30;120(9):1028-33. Norwegian.

26.

Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication.

Smith I, Lehmann AK, Lie L, Digranes A, Caugant DA, Høiby EA, Frøholm LO, Halstensen A.

Epidemiol Infect. 1999 Dec;123(3):373-82.

27.
28.

[Once-daily dosage of aminoglycosides--a therapeutic simplification and an economical benefit].

Berild D, Sjursen H, Digranes A.

Tidsskr Nor Laegeforen. 1999 Sep 10;119(21):3152-6. Review. Norwegian.

PMID:
10522483
29.
30.

Low faecal carrier rate of vancomycin resistant enterococci in Norwegian hospital patients.

Simonsen GS, Andersen BM, Digranes A, Harthug S, Jacobsen T, Lingaas E, Natås OB, Olsvik O, Ringertz SH, Skulberg A, Syversen G, Sundsfjord A.

Scand J Infect Dis. 1998;30(5):465-8.

PMID:
10066045
31.

[Infections caused by multiresistant enterococci in Norway].

Harthug S, Langeland N, Digranes A, Simonsen GS, Olsvik O, Sundsfjord A, Natås OB, Haarr E, Gaustad P, Høiby EA, Svarva PL.

Tidsskr Nor Laegeforen. 1998 Oct 30;118(26):4070-3. Review. Norwegian.

PMID:
9844510
32.

Constant low rate of fungemia in norway, 1991 to 1996. The Norwegian Yeast Study Group.

Sandven P, Bevanger L, Digranes A, Gaustad P, Haukland HH, Steinbakk M.

J Clin Microbiol. 1998 Dec;36(12):3455-9.

33.

Antibiotic susceptibility of blood culture isolates of Enterobacteriaceae from six Norwegian hospitals 1991-1992.

Digranes A, Solberg CO, Sjursen H, Skovlund E, Sander J.

APMIS. 1997 Nov;105(11):854-60.

PMID:
9393556
34.

Candida norvegensis: a fluconazole-resistant species.

Sandven P, Nilsen K, Digranes A, Tjade T, Lassen J.

Antimicrob Agents Chemother. 1997 Jun;41(6):1375-6.

35.

Susceptibility testing of bacteria and fungi. Report from "the Norwegian Working Group on Antibiotics".

Bergan T, Bruun JN, Digranes A, Lingaas E, Melby KK, Sander J.

Scand J Infect Dis Suppl. 1997;103:1-36. No abstract available.

PMID:
9253777
36.
37.

[Urinary tract infection in patients treated by self-catheterization. A prevalence study of patients using long term-intermittent catheterization].

Bakke A, Digranes A.

Tidsskr Nor Laegeforen. 1996 Sep 10;116(21):2552-5. Norwegian. No abstract available.

PMID:
8928123
38.

[Pyuria, bacteriuria and urinary tract infections in hospitalized patients with spinal cord injuries].

Tysnes OB, Krokeide M, Bjerke L, Digranes A.

Tidsskr Nor Laegeforen. 1996 Aug 10;116(18):2172-4. Norwegian.

PMID:
8801659
39.

Evaluation of a rapid enzyme immunoassay for detection of genital colonization of group B streptococci in pregnant women: own experience and review.

Hordnes K, Eide M, Ulstein M, Digranes A, Haneberg B.

Aust N Z J Obstet Gynaecol. 1995 Aug;35(3):251-3.

PMID:
8546636
40.

Systemic and mucosal antibody responses to group B streptococci following immunization of the colonic-rectal mucosa.

Hordnes K, Digranes A, Haugen IL, Helland DE, Ulstein M, Jonsson R, Haneberg B.

J Reprod Immunol. 1995 Mar;28(3):247-62.

PMID:
7473434
41.

Strain differentiation of Neisseria meningitidis by small-fragment restriction endonuclease analysis (SF-REA).

Mylvaganam H, Gilja OH, Halstensen A, Høiby EA, Digranes A, Bjorvatn B.

APMIS. 1995 Feb;103(2):147-53.

PMID:
7748539
42.

Double-blind comparison of ofloxacin for 3 days and placebo in acute bacterial enteritis.

Halstensen A, Voltersvik P, Gossius G, Digranes A, Peterson LE, Rolstad T, Solberg CO.

Drugs. 1995;49 Suppl 2:454-6. No abstract available.

PMID:
8549398
43.

Single dose ofloxacin in the eradication of pharyngeal carriage of Neisseria meningitidis.

Halstensen A, Gilja OH, Digranes A, Mylvaganam H, Aksnes A, Høiby EA, Rolstad T.

Drugs. 1995;49 Suppl 2:399-400. No abstract available.

PMID:
8549376
44.

Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women.

Baerheim A, Larsen E, Digranes A.

Scand J Prim Health Care. 1994 Dec;12(4):239-43.

PMID:
7863140
45.

Bloodstream infections at a Norwegian university hospital, 1974-1979 and 1988-1989: changing etiology, clinical features, and outcome.

Haug JB, Harthug S, Kalager T, Digranes A, Solberg CO.

Clin Infect Dis. 1994 Aug;19(2):246-56.

PMID:
7986895
46.

Mixed bacteremia with Vibrio metschnikovii in an 83-year-old female patient.

Hardardottir H, Vikenes K, Digranes A, Lassen J, Halstensen A.

Scand J Infect Dis. 1994;26(4):493-4.

PMID:
7984986
47.

Use of single-dose ofloxacin to eradicate tonsillopharyngeal carriage of Neisseria meningitidis.

Gilja OH, Halstensen A, Digranes A, Mylvaganam H, Aksnes A, Høiby EA.

Antimicrob Agents Chemother. 1993 Sep;37(9):2024-6.

48.

Assessment of clinical features predicting streptococcal pharyngitis.

Meland E, Digranes A, Skjaerven R.

Scand J Infect Dis. 1993;25(2):177-83.

PMID:
8511511
49.

Evaluation of urine sampling technique: bacterial contamination of samples from women students.

Baerheim A, Digranes A, Hunskaar S.

Br J Gen Pract. 1992 Jun;42(359):241-3.

50.

Temafloxacin: in vitro comparison with five other antibacterial agents.

Digranes A, Hardardottir H, Bottolfsen KL.

Chemotherapy. 1991;37(2):98-105.

PMID:
2032475

Supplemental Content

Loading ...
Support Center